An observational study in Dystonia and Parkinsonism, sponsored by State University of New York at Buffalo. Active, not recruiting at 2 sites in United States. Open to participants aged 6 Years and older. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by State University of New York at Buffalo · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 118 studies in Dystonia with a site in United States — 27 open to participants now, 31 under way, none of them phase 3. Dystonia · United States.
Among the 118 studies in Dystonia with a site in United States, this one is the 15th largest by planned enrollment of the 56 observational ones that give a count, is one of 6 that started in 2008, is one of 56 observational ones, reaches primary completion later than 6 of the 30 other live ones, and was the 25th registered.
213 studies on the registry are indexed under Dystonia; 54 are open to participants now.
Browse Dystonia studies →27 of the 118 studies in Dystonia with a site in United States are open now. Recruiting first, the newest first:
University of Pennsylvania · Sites in United States
Ages 18+
Children's Hospital Medical Center, Cincinnati · Sites in United States
Ages 6–21 · Healthy volunteers
Northwell Health · Sites in United States
Ages 18–80
Vima Therapeutics · Sites in United States, Canada
Ages 18–70
Mayo Clinic · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 41 Dystonia studies recruiting now, 19 (46%) set no upper age limit and 10 (24%) stop at 75 or younger; 18 take children under 18; 6 take healthy volunteers.
This study: 6 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
118 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 9 · Phase 2 21 · Phase 3 3 · Phase 4 3
First in 1997; this study’s year is marked. 6 started in 2008.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 198 is above the median of 78 across 90 observational studies indexed under Dystonia.
Median enrollment 22 across the 61 interventional studies, 80 across the 56 observational. Of the 81 that completed or were terminated, 20 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 118 have an industry lead sponsor. The 10 most frequent:
State University of New York at Buffalo is the lead sponsor of 294 studies on the registry; 63 are open to participants now.
Of its 19 completed or terminated interventional studies of FDA-regulated products, 15 (79%) have results posted.
State University of New York at Buffalo has 1 study filed under Dystonia — fewer than ten, so there is no comparison to draw.
9 of the studies in Dystonia with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07111663Vima TherapeuticsAn Observational Study of Individuals With Isolated Dystonia | 2026-11 |
| NCT04286308Massachusetts General HospitalCortical-Basal Ganglia Speech Networks | 2027-02 |
| NCT02553525Duke UniversityEffects of Stimulation Patterns of Deep Brain Stimulation | 2027-03 |
| NCT07304089Vima TherapeuticsA Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia | 2027-03 |
| NCT00682513State University of New York at BuffaloStudies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders | 2027-07-31 |
Add all 9 to your calendar (.ics) → With an account.
Among the 118 studies in Dystonia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purposes of this study are to identify persons with rapid-onset dystonia-parkinsonism (RDP) or mutations of the RDP gene, document prevalence of the disease, and map its natural history.
Rapid-onset dystonia-parkinsonism (RDP) is a rare, movement disorder with variable characteristics ranging from sudden onset (hours to days) of severe dystonic spasms to gradual onset of writer's cramp. RDP has elements of both dystonia and Parkinson's disease-two neurological diseases with motor and neuropsychological symptoms that hinder the quality of life. An internal trigger associated with extreme physiological stress has been reported prior to abrupt symptom onset of RDP.
This study, which is a continuation of an earlier study begun by Dr. Allison Brashear, aims to more clearly identify the characteristics associated with RDP and to explore whether mutations in the RDP gene are associated with atypical dystonias, Parkinson's disease, and other movement disorders.
The study involves in-person or remote (telemedicine) neurological assessments and blood samples for genetic analysis.
Selection will take place predominantly via primary care clinics, i.e., physician referrals when patients present with a movement disorder suspicious for RDP.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Those with RDP, AHC, unaffected carriers of ATP1A3 mutations, and non-carrying family members
RDP Severity
History of symptom onset and duration will be obtained and current degree of severity assessed.
Time frame: Visit 1 (baseline)
Presence of neuropsychiatric disease
Psychiatric interview and cognitive assessment will be performed to examine presence or absence of symptoms.
Time frame: Will be assessed at Visits 1 (baseline) and 2 (24 months), approximately 2 years apart
Plan to share: No
The record gives a start of Apr 2008, a primary completion of Jul 2027 and a completion of Jul 2027. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
State University of New York at Buffalo →